Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Archives of General Psychiatry

• Publication date

  1986-10-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1001/ARCHPSYC.1986.01800100039006PMID 3019267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 3H-Imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers

  2004cited by this paper
• High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers

  2004cited by this paper
• Platelet 3H-imipramine binding and steroid hormones serum concentrations during the menstrual cycle

  2004cited by this paper
• Tritiated imipramine binding distinguishes among subtypes of depression.

  1985cited by this paper
• Human plasma inhibitors of platelet serotonin uptake and imipramine receptor binding: extraction and heterogeneity.

  1985cited by this paper
• Demonstration of endogenous "imipramine like" material in rat brain.

  1985cited by this paper
• Binding of [3H]Imipramine to Human Platelet Membranes with Compensation for Saturable Binding to Filters and Its Implication for Binding Studies with Brain Membranes

  1984cited by this paper
• [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.

  1984cited by this paper
• Inhibition of synaptosomal 5‐[3H]hydroxytryptamine uptake by endogenous factor(s) in human blood

  1984cited by this paper
• Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis.

  1983cited by this paper
• Decreased Imipramine Binding in the Brains of Patients with Depressive Illness

  1983cited by this paper
• Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.

  1983cited by this paper
• 3H-imipramine binding sites in platelets from psychiatric patients.

  1982cited by this paper
• Tritiated imipramine binding sites are decreased in the frontal cortex of suicides.

  1982cited by this paper
• Concomitant decrease in [3H]imipramine binding in cat brain and platelets after chronic treatment with imipramine.

  1982cited by this paper
• Different synaptic location of mianserin and imipramine binding sites.

  1982cited by this paper
• Normalization of platelet [3H]imipramine binding in depressed patients during remission.

  1982cited by this paper
• Platelet 3H-imipramine binding in euthymic bipolar patients.

  1982cited by this paper
• 3H-imipramine binding sites in the rat brain

  1981cited by this paper
• Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".

  1981cited by this paper
• Regional distribution of [3H]imipramine binding in rat brain.

  1981cited by this paper
• Distribution of Specific High‐Affinity Binding Sites for [3H]Imipramine in Human Brain

  1981cited by this paper
• Localisation of Tricyclic Antidepressant Binding Sites on Serotonin Nerve Terminals

  1981cited by this paper
• High-affinity 3H-imipramine binding: a new biological tool for studies in depression

  1981cited by this paper
• High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine.

  1980cited by this paper
• Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients.

  1980cited by this paper
• Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine.

  1980cited by this paper
• Demonstration of specific high affinity binding sites for [3H] imipramine in human brain.

  1980cited by this paper
• Demonstration of specific "high affinity" binding sites for [3H] imipramine on human platelets.

  1980cited by this paper
• Specific 3H-imipramine binding in human platelets

  1980cited by this paper
• Decreased 3H-imipramine binding in depressed males and females.

  1980cited by this paper
• Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding.

  1980cited by this paper
• Human platelets possess high-affinity binding sites for 3H-imipramine.

  1979cited by this paper
• Specific tricyclic antidepressant binding sites in rat brain

  1979cited by this paper
• High-affinity 3H-imipramine binding in rat cerebral cortex.

  1979cited by this paper
• Depressive illness : some research studies

  1973cited by this paper

• Effects of repetitive administration of tianeptine, zinc hydroaspartate and electroconvulsive shock on the reactivity of 5-HT(7) receptors in rat hippocampus.

  2007cites this paper
• Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors

  2006cites this paper
• Ritanserin, a 5-HT2 receptor antagonist, does not modify ECT-induced prolactin release

  2005cites this paper
• Theories on Mechanism of Action of Electroconvulsive Therapy

  2005cites this paper
• Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding

  2004cites this paper
• Platelet serotonin transport after a single ECT

  2004cites this paper
• Alterations in platelet serotonin transporter binding in women with postpartum onset major depression.

  2004cites this paper
• Electroconvulsive shock increases serotonin transporter in the rat frontal cortex.

  2003cites this paper
• Platelet serotonin transporter in stroke patients

  2003cites this paper
• ECT literature: frequently cited papers and their impact on the field.

  2002cites this paper
• Electroconvulsive shock regulates serotonin transporter mRNA expression in rat raphe nucleus

  2001cites this paper
• Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.

  2001cites this paper
• [Electroconvulsive therapy and serotonergic system].

  2000cites this paper
• Neurobiological Correlates of the Antidepressant Action of Electroconvulsive Therapy

  1998cites this paper
• Old age depression-a biological inevitability?

  1996cites this paper
• Electroconvulsive therapy down-regulates platelet peripheral-type benzodiazepine receptors in medication-resistant major depressed patients.

  1996cites this paper
• Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disorders

  1995cites this paper
• Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.

  1995cites this paper
• Single or repeated treatment with electroconvulsive shock increases number of serotonin uptake binding sites in the frontal cortex.

  1995cites this paper
• Further studies on platelet serotonin transporter binding in depression.

  1994cites this paper
• Is platelet imipramine binding reduced in depression? A meta-analysis.

  1994cites this paper
• Lack of association between platelet tritiated imipramine binding and clinical status of depressed patients on chronic antidepressant treatment.

  1994cites this paper
• Tritiated platelet imipramine binding and treatment response in depressed outpatients

  1993cites this paper
• A single electroconvulsive treatment affects platelet serotonin uptake in bipolar I patients.

  1993cites this paper
• The influence of psychotherapy and depression on platelet imipramine and paroxetine binding.

  1992cites this paper
• Platelet 3H‐imipramine binding during recovery from depression

  1992cites this paper
• Platelet imipramine binding in depressed children and adolescents.

  1992cites this paper
• Personality features and platelet 3H-imipramine binding.

  1992cites this paper
• Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.

  1992cites this paper
• ECT treatment does not enhance neuroendocrine responses to serotonergic challenge

  1992cites this paper
• Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome.

  1992cites this paper
• Rapid changes in 3H‐imipramine platelet binding after chronic treatment with amineptine, a selective dopamine uptake blocker, in major depressed patients

  1992cites this paper
• Peripheral markers in anxiety and depression.

  1992cites this paper
• Platelet [3H]imipramine and alpha 2-adrenoceptor binding in normal subjects during desipramine administration and withdrawal.

  1991cites this paper
• PERIPHERAL MARKERS IN AFFECTIVE DISORDERS

  1991cites this paper
• Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3 H‐imipramine binding and serotonin uptake and concentration in major depressive disorder

  1991cites this paper
• Platelet tritiated imipramine binding in patients suffering from mania.

  1991cites this paper
• Circadian variation in platelet imipramine binding during the day in healthy subjects.

  1991cites this paper
• Circadian Variation in Platelet Imipramine Binding During the Day in Healthy Subjects

  1991cites this paper
• Platelet 3H-imipramine binding in major depressive episodes

  1991cites this paper
• Long-term verapamil treatment increases [3H]imipramine binding in human platelets.

  1990cites this paper
• Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.

  1990influential citation
• Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women.

  1990cites this paper
• Eating disorders and depression: is there a serotonin connection?

  1990cites this paper
• Effects of chronic imipramine treatment on subclasses of platelet 3H-imipramine binding sites and plasma cortisol.

  1990cites this paper
• Blood platelets as a model system for studying serotonergic dysfunction and effects of antidepressants.

  1990cites this paper
• Platelet tritiated imipramine binding in psychiatric patients: relationship to symptoms and severity of depression

  1990cites this paper
• Biological Markers in Geriatric Depression

  1990cites this paper
• Blood platelets as a model system for studying serotonergic dysfunction and effects of antidepressants.

  1990cites this paper
• Selective breeding in rats for extreme densities of platelet 3H-imipramine binding sites: evidence against a trait hypothesis.

  1989cites this paper
• Genetic Studies of Affective Illness

  1989cites this paper
• Platelet 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression.

  1989cites this paper
• Lack of specificity of reduced platelet imipramine binding in different psychiatric conditions.

  1989cites this paper
• Neuropsychological and Biomedical Assessment of

  1989cites this paper
• Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent.

  1989cites this paper
• Platelet 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression.

  1989cites this paper
• 3H-imipramine binding to freshly prepared platelet membranes in depression.

  1989cites this paper
• Presynaptic Sites of Antidepressant Action: Monoamine Transport Systems and Release-Modulating Autoreceptors

  1989cites this paper
• BINDING OF IMIPRAMINE TO PLATELET MEMBRANES IS REDUCED IN PANIC ATTACKS

  1988cites this paper
• Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression.

  1988cites this paper
• Effect of desipramine treatment on 3H-imipramine binding in the blood platelets of depressed patients.

  1988cites this paper
• High-affinity 3H-imipramine binding sites: a possible state-dependent marker for major depression.

  1988cites this paper
• Decreased platelet 3H-imipramine binding in primary major depression compared with depression secondary to medical illness in elderly outpatients.

  1988cites this paper
• Studies on the serotonin transporter in platelets

  1988cites this paper
• Imipramine binding in depression and other psychiatric conditions

  1988cites this paper
• Imipramine binding in platelets of patients with panic disorder.

  1988cites this paper
• Urinary MHPG, platelet 3H-imipramine binding and symptomatology in depression: an exploratory study of clinical heterogeneity.

  1988cites this paper
• Platelet 3H-imipramine binding and response to minaprine in patients with major depression.

  1988cites this paper
• Platelet 3H-lmipramine Binding and Response to Minaprine in Patients with Major Depression

  1988cites this paper
• Neuroendocrine aspects of suicidal behavior.

  1988cites this paper
• Effects of antidepressants on monoamine transporters.

  1988cites this paper
• Review of Imipramine Binding in Platelets from Psychiatric Patients: Its Relevance to the Biology of Suicide

  1988cites this paper
• Changes in platelet 3H-imipramine binding in depressed patients receiving electroconvulsive therapy.

  1988cites this paper
• Advances in the diagnosis and management of depression. Part I.

  1988cites this paper
• Methysergide reduces the prolactin response to ECT.

  1988cites this paper
• Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.

  1987cites this paper
• Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.

  1987cites this paper
• Dieting and weight loss in volunteers increases the number of alpha 2-adrenoceptors and 5-HT receptors on blood platelets without effect on [3H]imipramine binding.

  1987cites this paper
• Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorder.

  1987cites this paper
• Platelet tritiated imipramine binding and serotonin uptake in depressed patients and controls. Relationship to plasma cortisol levels before and after dexamethasone administration.

  1987cites this paper
• Platelet tritiated imipramine binding and serotonin uptake in depressed patients and controls. Relationship to plasma cortisol levels before and after dexamethasone administration.

  1987cites this paper
• Antidepressant-binding sites in brain and platelets.

  1986cites this paper
• Lack of seasonal variation in platelet [3H]imipramine binding in humans.

  1986cites this paper